Clementia Pharmaceuticals Inc. (CMTA) Return on Investment ROI from the fourth quarter of 2018 to fourth quarter of 2017 and for the year 2018, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Clementia Pharmaceuticals Inc.  (CMTA)


Clementia Pharmaceuticals's ROI from its fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Clementia Pharmaceuticals's ROI in the fourth quarter of 2018?
Clementia Pharmaceuticals Inc. recorded a cumulative net loss of $-58 million during 12 months ending in the fourth quarter of 2018, resulting in a negative return on investment (ROI) of -43.29%.

Within the Healthcare sector 408 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2018 from 0 to 4405.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 164 107 128 138 148
Return On Investment (TTM) -43.29 % -38.82 % -52.12 % -145.64 % 569.14 %
CMTA's Overall Ranking # 4405 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 3.07 % -9.22 % 139.25 % - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -58 -51 -75 -87 -115

CMTA Company Profile >> Back to CMTA Roi Comparisons >> See Annual CMTA Return On Investment



Return On Investment CMTA's Ranking
Within: No.
Industry # 180
Sector # 409
Overall # 4405

Return On Investment Statistics
High Average Low
-35.35 %
-35.35 %
-35.35 %
(Dec 31 2018)  







Financial Statements
Clementia Pharmaceuticals's IV. Quarter Investments $ 164 Millions CMTA's Balance sheet
Clementia Pharmaceuticals's IV. Quarter Income $ -19 Millions Quarterly CMTA's Income Statement
CMTA's Income by Division See CMTA's Income by Division


CMTA Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017


Total Investments in Millions 164 148 0 0 0
Y / Y Investment Growth 10.78 % - - - -
Net Income in Millions -58 -115 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.35 % -77.79 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CMTA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CMTA's Competitors
Subscribers only: Roi for Clementia Pharmaceuticals's Suppliers
Subscribers only: Return On Investment for CMTA's Customers

Other Ratios
CMTA's Roa CMTA's Inventory Turnover Ratio CMTA's Growth Rates CMTA's Dividend Statistics
CMTA's Profitability Ratios CMTA's Asset Turnover Ratio CMTA's Dividend Growth
CMTA's Roe CMTA's Valuation Ratios CMTA's Financial Strength Ratios CMTA's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2018, within Healthcare Sector ROI

Date modified: 2026-09-05T11:07:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.